Lihui Zou

753 total citations
38 papers, 570 citations indexed

About

Lihui Zou is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Lihui Zou has authored 38 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 12 papers in Cancer Research. Recurrent topics in Lihui Zou's work include Cancer Genomics and Diagnostics (4 papers), Cancer-related molecular mechanisms research (4 papers) and Circular RNAs in diseases (4 papers). Lihui Zou is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Cancer-related molecular mechanisms research (4 papers) and Circular RNAs in diseases (4 papers). Lihui Zou collaborates with scholars based in China, United States and Germany. Lihui Zou's co-authors include Fei Xiao, Junhua Jin, Wenqing Li, Wei Huang, Fei Su, Xiaoxia Wang, Qi Pan, Junhua Zhang, Yuan Fang and Junhua Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and SHILAP Revista de lepidopterología.

In The Last Decade

Lihui Zou

34 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lihui Zou China 14 365 268 90 65 40 38 570
Ondrej Pös Slovakia 12 400 1.1× 358 1.3× 66 0.7× 79 1.2× 15 0.4× 20 696
Erik H. Koritzinsky United States 9 409 1.1× 224 0.8× 31 0.3× 52 0.8× 20 0.5× 12 575
Guofeng Shao China 14 417 1.1× 234 0.9× 60 0.7× 42 0.6× 59 1.5× 31 582
Farah Rahmatpanah United States 13 463 1.3× 118 0.4× 130 1.4× 89 1.4× 20 0.5× 26 663
Chenkui Miao China 15 357 1.0× 209 0.8× 129 1.4× 110 1.7× 13 0.3× 43 576
Yoko Ino Japan 13 282 0.8× 97 0.4× 52 0.6× 87 1.3× 22 0.6× 37 510
Jun‐Hyuk Choi South Korea 13 384 1.1× 95 0.4× 64 0.7× 74 1.1× 41 1.0× 26 593
Beáta Soltész Hungary 12 370 1.0× 316 1.2× 44 0.5× 51 0.8× 25 0.6× 31 594
Stefan K. Grebe United States 10 551 1.5× 521 1.9× 50 0.6× 60 0.9× 32 0.8× 23 835
Míriam Méndez Spain 12 245 0.7× 154 0.6× 120 1.3× 168 2.6× 18 0.5× 54 528

Countries citing papers authored by Lihui Zou

Since Specialization
Citations

This map shows the geographic impact of Lihui Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lihui Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lihui Zou more than expected).

Fields of papers citing papers by Lihui Zou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lihui Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lihui Zou. The network helps show where Lihui Zou may publish in the future.

Co-authorship network of co-authors of Lihui Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Lihui Zou. A scholar is included among the top collaborators of Lihui Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lihui Zou. Lihui Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yanxia, Bingxi He, Haibo Xu, et al.. (2025). Evidence that metformin promotes fibrosis resolution via activating alveolar epithelial stem cells and FGFR2b signaling. Acta Pharmaceutica Sinica B. 15(9). 4711–4729.
2.
Zou, Lihui, Jing Chen, Li Xie, et al.. (2025). Landscape of T Cells in Tuberculous Pleural Effusion. The Clinical Respiratory Journal. 19(4). e70066–e70066.
3.
Sun, Tao, Mengyao Li, Ye Liu, et al.. (2025). Revolutionizing Heart Failure Therapy: Harnessing IVT mRNA and Fusion Protein Technology to Prolong rhBNP Half-Life. Pharmaceutical Research. 42(1). 137–149. 1 indexed citations
4.
Zhang, Lili, Yifei Li, Chang Li, et al.. (2024). Full-Length Immune Repertoire Reconstruction and Profiling at the Transcriptome Level Using Long-Read Sequencing. Clinical Chemistry. 71(2). 274–285.
5.
Zhang, Lili, Jian Cui, Qi An, et al.. (2023). Small extrachromosomal circular DNAs as biomarkers for multi‐cancer diagnosis and monitoring. Clinical and Translational Medicine. 13(9). e1393–e1393. 19 indexed citations
6.
Li, Chang, Yibo Xie, Zaifeng Zhang, et al.. (2023). Structural and functional prediction, evaluation, and validation in the post-sequencing era. Computational and Structural Biotechnology Journal. 23. 446–451. 3 indexed citations
7.
Zhang, Zaifeng, Ye Liu, Chang Li, et al.. (2023). A precise and efficient circular RNA synthesis system based on a ribozyme derived from Tetrahymena thermophila. Nucleic Acids Research. 51(14). e78–e78. 22 indexed citations
8.
Yang, Pengbo, et al.. (2023). Communications between macrophages and cardiomyocytes. Cell Communication and Signaling. 21(1). 206–206. 20 indexed citations
9.
Chen, Meng, et al.. (2022). Circular RNAs: Biomarkers of cancer. SHILAP Revista de lepidopterología. 1(3). 197–206. 12 indexed citations
10.
Zhang, Junhua, et al.. (2022). Modifying a bacterial tyrosinase zymogen for use in protease activity assays. Applied Microbiology and Biotechnology. 106(24). 8285–8294. 1 indexed citations
11.
Su, Fei, Ming Liu, Yaoguang Zhang, et al.. (2022). Bacillus Calmette–Guérin Treatment Changes the Tumor Microenvironment of Non-Muscle-Invasive Bladder Cancer. Frontiers in Oncology. 12. 842182–842182. 2 indexed citations
12.
Wu, Qingjun, Hexin Li, Lili Zhang, et al.. (2021). Identification of differentially expressed circular RNAs associated with thymoma. Thoracic Cancer. 12(9). 1312–1319. 9 indexed citations
13.
Cui, Hongyuan, Mingwei Zhu, Junhua Zhang, et al.. (2020). Identification of Differentially Expressed Genes Associated with Papillary Thyroid Carcinoma. Combinatorial Chemistry & High Throughput Screening. 23(6). 546–553. 2 indexed citations
14.
Zhang, Junhua, Yaoguang Zhang, Dalei Zhang, et al.. (2019). Abiraterone and MDV3100 inhibits the proliferation and promotes the apoptosis of prostate cancer cells through mitophagy. Cancer Cell International. 19(1). 332–332. 20 indexed citations
15.
Su, Fei, Yaoguang Zhang, Dalei Zhang, et al.. (2018). Spatial Intratumor Genomic Heterogeneity within Localized Prostate Cancer Revealed by Single-nucleus Sequencing. European Urology. 74(5). 551–559. 32 indexed citations
16.
Zou, Lihui, Jing Liang, Xin Wang, et al.. (2018). The Urinary Sarcosine/Creatinine Ratio is a Potential Diagnostic and Prognostic Marker in Prostate Cancer. Medical Science Monitor. 24. 3034–3041. 24 indexed citations
17.
Zou, Lihui, Junhua Zhang, Fei Su, et al.. (2018). cGMP interacts with tropomyosin and downregulates actin-tropomyosin-myosin complex interaction. Respiratory Research. 19(1). 201–201. 2 indexed citations
18.
Jin, Junhua, Lihui Zou, Lin Li, et al.. (2016). AFP mRNA level in enriched circulating tumor cells from hepatocellular carcinoma patient blood samples is a pivotal predictive marker for metastasis. Cancer Letters. 378(1). 33–37. 37 indexed citations
19.
Zou, Lihui, Haijian Zhao, Daguang Wang, et al.. (2014). Expression and Purification of a Functional Recombinant Aspartate Aminotransferase (AST) from Escherichia coli. Journal of Microbiology and Biotechnology. 24(7). 998–1003. 8 indexed citations
20.
Zou, Lihui, et al.. (2011). Lasting Controversy on Ranibizumab and Bevacizumab. Theranostics. 1. 395–402. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026